Highlights argenx SE Nasdaq

Equities

ARGX

US04016X1019

Market Closed - Nasdaq Other stock markets 01:30:00 01/06/2024 am IST			5-day change	1st Jan Change
371 ^USD	+2.45%		+1.08%	-2.47%

30/05	European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading	MT
29/05	European Equities Traded in the US as American Depositary Receipts Trend Sharply Lower in Wednesday Trading	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading	30/05	MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Friday Trading	17/05	MT
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Wednesday Trading	15/05	MT
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading; End Week Up Nearly 3%	10/05	MT
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading	09/05	MT
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday Amid Fading Rate Cut Hopes	09/05	MT
Europe's STOXX 600 pauses after recent rally; BBVA weighs on Spain	09/05	RE
Argenx Q1 Loss Widens, Total Operating Income Rises	09/05	MT
European shares pause after recent rally, BoE decision in focus	09/05	RE
Argenx SE Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05	CI
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Set to Close Week Lower	03/05	MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	17/04	MT
Argenx SE Announces Data from its Phase 3 ADHERE Trial Evaluating VYVGART Hytrulo in Patients with Chronic Inflammatory Demyelinating Polyneuropathy	16/04	CI
European Equities Traded in the US as American Depositary Receipts Trend Higher in Thursday Trading	04/04	MT
Argenx Se Advances Clinical Development of Efgartigimod in Primary Sjogren's Disease	27/03	CI
Argenx SE Announces Approval of Vyvgart (Efgartigimod Alfa) in Japan for Adults with Primary Immune Thrombocytopenia	26/03	CI
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading	21/03	MT
US Futures, European Stocks Rise After Fed Maintains Outlook	21/03	DJ
Global markets live: HP, Moncler, Snowflake, Salesforce, Duolingo...	29/02
Argenx Q4 Loss Widens, Revenue Increases -- Shares Down Pre-Bell	29/02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights argenx SE Nasdaq

Equities

ARGX

US04016X1019

Highlights

Filters